Provided By GlobeNewswire
Last update: Oct 22, 2025
Company previously announced it was selected as a finalist from more than 1,800 submissions
Award win underscores growing impact of Aclarion’s breakthrough Nociscan solution for chronic low back pain
Read more at globenewswire.comNASDAQ:ACONW (11/4/2025, 8:00:00 PM)
0.04
-0.01 (-17.86%)
NASDAQ:ACON (11/5/2025, 1:39:04 PM)
7.55
+0.05 (+0.67%)
Find more stocks in the Stock Screener


